 Javier Valle
Concepts (236)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Percutaneous Coronary Intervention | 33 | 2023 | 444 | 7.640 |
Why?
| | Coronary Artery Disease | 21 | 2023 | 607 | 4.340 |
Why?
| | Coronary Angiography | 15 | 2023 | 304 | 2.480 |
Why?
| | Peripheral Arterial Disease | 7 | 2022 | 380 | 2.020 |
Why?
| | Myocardial Infarction | 15 | 2022 | 927 | 2.010 |
Why?
| | Registries | 16 | 2023 | 1768 | 1.990 |
Why?
| | Angioplasty, Balloon | 5 | 2022 | 88 | 1.800 |
Why?
| | Transcatheter Aortic Valve Replacement | 5 | 2022 | 152 | 1.730 |
Why?
| | ST Elevation Myocardial Infarction | 3 | 2019 | 50 | 1.700 |
Why?
| | Cardiovascular Agents | 3 | 2023 | 126 | 1.660 |
Why?
| | Coronary Artery Bypass | 7 | 2023 | 196 | 1.570 |
Why?
| | Veterans | 10 | 2023 | 1249 | 1.530 |
Why?
| | Veterans Health | 8 | 2020 | 165 | 1.450 |
Why?
| | Vascular Calcification | 7 | 2022 | 107 | 1.420 |
Why?
| | Femoral Artery | 7 | 2022 | 167 | 1.400 |
Why?
| | United States Department of Veterans Affairs | 18 | 2021 | 561 | 1.340 |
Why?
| | Coronary Vessels | 4 | 2020 | 227 | 1.190 |
Why?
| | Treatment Outcome | 37 | 2023 | 9088 | 1.190 |
Why?
| | Platelet Aggregation Inhibitors | 5 | 2019 | 401 | 1.160 |
Why?
| | Time-to-Treatment | 2 | 2019 | 147 | 1.150 |
Why?
| | Ischemia | 4 | 2019 | 362 | 1.140 |
Why?
| | Myocardial Revascularization | 5 | 2019 | 67 | 1.080 |
Why?
| | Surgical Procedures, Operative | 6 | 2018 | 207 | 1.080 |
Why?
| | Endovascular Procedures | 4 | 2019 | 269 | 1.080 |
Why?
| | Atherectomy | 7 | 2022 | 33 | 1.060 |
Why?
| | Aortic Valve Stenosis | 5 | 2022 | 272 | 1.050 |
Why?
| | Preoperative Care | 3 | 2018 | 319 | 0.990 |
Why?
| | Lower Extremity | 3 | 2018 | 335 | 0.980 |
Why?
| | Hospital Mortality | 8 | 2021 | 776 | 0.980 |
Why?
| | Coronary Occlusion | 2 | 2023 | 18 | 0.980 |
Why?
| | United States | 34 | 2021 | 12186 | 0.950 |
Why?
| | Risk Factors | 29 | 2023 | 8632 | 0.940 |
Why?
| | Aged | 38 | 2022 | 19074 | 0.890 |
Why?
| | Angioplasty, Balloon, Coronary | 3 | 2013 | 146 | 0.860 |
Why?
| | Catheterization, Peripheral | 3 | 2021 | 101 | 0.850 |
Why?
| | Hospitals, Veterans | 3 | 2020 | 244 | 0.840 |
Why?
| | Embolic Protection Devices | 2 | 2021 | 11 | 0.830 |
Why?
| | Non-ST Elevated Myocardial Infarction | 2 | 2019 | 16 | 0.780 |
Why?
| | Time Factors | 23 | 2020 | 6116 | 0.770 |
Why?
| | Technology Transfer | 1 | 2021 | 13 | 0.760 |
Why?
| | Radial Artery | 3 | 2021 | 66 | 0.760 |
Why?
| | Coated Materials, Biocompatible | 4 | 2022 | 54 | 0.690 |
Why?
| | Humans | 72 | 2023 | 114705 | 0.690 |
Why?
| | Middle Aged | 33 | 2021 | 26738 | 0.680 |
Why?
| | Risk Assessment | 16 | 2022 | 2968 | 0.670 |
Why?
| | Heart Arrest | 3 | 2019 | 293 | 0.670 |
Why?
| | Hemorrhage | 5 | 2018 | 620 | 0.660 |
Why?
| | Aspirin | 2 | 2019 | 324 | 0.640 |
Why?
| | Heart Valve Prosthesis Implantation | 2 | 2021 | 174 | 0.640 |
Why?
| | Saphenous Vein | 1 | 2019 | 31 | 0.640 |
Why?
| | Graft Occlusion, Vascular | 1 | 2019 | 35 | 0.640 |
Why?
| | Male | 45 | 2021 | 55607 | 0.630 |
Why?
| | Centralized Hospital Services | 1 | 2018 | 6 | 0.630 |
Why?
| | Healthcare Disparities | 3 | 2018 | 480 | 0.610 |
Why?
| | Fibrinolytic Agents | 2 | 2018 | 234 | 0.590 |
Why?
| | Transportation of Patients | 1 | 2018 | 52 | 0.590 |
Why?
| | Arm | 1 | 2018 | 104 | 0.580 |
Why?
| | Peripheral Vascular Diseases | 1 | 2018 | 97 | 0.580 |
Why?
| | Inferior Wall Myocardial Infarction | 1 | 2017 | 2 | 0.570 |
Why?
| | Heart Rupture, Post-Infarction | 1 | 2017 | 3 | 0.570 |
Why?
| | Papillary Muscles | 1 | 2017 | 14 | 0.570 |
Why?
| | Endarterectomy, Carotid | 1 | 2017 | 42 | 0.570 |
Why?
| | Decision Support Systems, Clinical | 1 | 2019 | 176 | 0.560 |
Why?
| | Myocardial Ischemia | 1 | 2018 | 235 | 0.560 |
Why?
| | Tibial Arteries | 1 | 2017 | 12 | 0.560 |
Why?
| | Female | 43 | 2021 | 59521 | 0.550 |
Why?
| | Renal Artery | 1 | 2017 | 26 | 0.550 |
Why?
| | Atherectomy, Coronary | 3 | 2022 | 11 | 0.550 |
Why?
| | Renal Artery Obstruction | 1 | 2017 | 29 | 0.550 |
Why?
| | Carotid Stenosis | 1 | 2017 | 79 | 0.540 |
Why?
| | Disease Management | 2 | 2019 | 560 | 0.540 |
Why?
| | Popliteal Artery | 3 | 2022 | 57 | 0.530 |
Why?
| | Postoperative Complications | 6 | 2019 | 2128 | 0.510 |
Why?
| | Angiotensin Receptor Antagonists | 1 | 2016 | 76 | 0.510 |
Why?
| | Exercise Test | 1 | 2018 | 544 | 0.500 |
Why?
| | Obesity | 2 | 2019 | 2508 | 0.490 |
Why?
| | Ticlopidine | 1 | 2015 | 55 | 0.490 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2016 | 179 | 0.490 |
Why?
| | Anticoagulants | 2 | 2016 | 550 | 0.480 |
Why?
| | Practice Patterns, Physicians' | 3 | 2017 | 1177 | 0.480 |
Why?
| | Stents | 8 | 2020 | 475 | 0.480 |
Why?
| | Heart Diseases | 1 | 2018 | 331 | 0.480 |
Why?
| | Contrast Media | 1 | 2017 | 345 | 0.470 |
Why?
| | Cardiac Catheterization | 2 | 2017 | 534 | 0.460 |
Why?
| | Adrenergic beta-Antagonists | 1 | 2016 | 287 | 0.450 |
Why?
| | Mental Health | 1 | 2019 | 562 | 0.440 |
Why?
| | Heart Conduction System | 2 | 2013 | 80 | 0.430 |
Why?
| | Adrenergic Antagonists | 1 | 2013 | 9 | 0.430 |
Why?
| | Cohort Studies | 9 | 2021 | 4895 | 0.400 |
Why?
| | Health Services Accessibility | 1 | 2018 | 763 | 0.400 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2016 | 373 | 0.400 |
Why?
| | Stroke | 5 | 2022 | 1022 | 0.400 |
Why?
| | Odds Ratio | 7 | 2021 | 953 | 0.390 |
Why?
| | Mental Disorders | 1 | 2019 | 893 | 0.370 |
Why?
| | Patient Discharge | 2 | 2016 | 773 | 0.370 |
Why?
| | Diabetes Mellitus | 1 | 2018 | 900 | 0.360 |
Why?
| | Aged, 80 and over | 11 | 2021 | 6347 | 0.360 |
Why?
| | Acute Kidney Injury | 1 | 2017 | 638 | 0.350 |
Why?
| | Retrospective Studies | 20 | 2022 | 12556 | 0.350 |
Why?
| | Vascular Access Devices | 2 | 2020 | 24 | 0.340 |
Why?
| | Aortic Valve | 4 | 2022 | 398 | 0.330 |
Why?
| | Inpatients | 1 | 2013 | 380 | 0.330 |
Why?
| | Vascular Patency | 4 | 2020 | 97 | 0.280 |
Why?
| | Acute Coronary Syndrome | 2 | 2022 | 253 | 0.280 |
Why?
| | Follow-Up Studies | 7 | 2021 | 4411 | 0.280 |
Why?
| | Coronary Stenosis | 2 | 2017 | 39 | 0.280 |
Why?
| | Drug Therapy, Combination | 4 | 2019 | 951 | 0.280 |
Why?
| | Arterial Occlusive Diseases | 2 | 2018 | 74 | 0.260 |
Why?
| | Logistic Models | 5 | 2017 | 1841 | 0.260 |
Why?
| | Heart Failure | 1 | 2018 | 1945 | 0.260 |
Why?
| | Prognosis | 6 | 2021 | 3330 | 0.250 |
Why?
| | Survival Rate | 6 | 2021 | 1644 | 0.250 |
Why?
| | Limb Salvage | 3 | 2019 | 52 | 0.230 |
Why?
| | Comorbidity | 3 | 2019 | 1448 | 0.230 |
Why?
| | Propensity Score | 3 | 2021 | 224 | 0.230 |
Why?
| | Incidence | 7 | 2019 | 2313 | 0.220 |
Why?
| | Predictive Value of Tests | 5 | 2018 | 1796 | 0.210 |
Why?
| | Cardiovascular Diseases | 3 | 2020 | 1727 | 0.200 |
Why?
| | Practice Guidelines as Topic | 3 | 2019 | 1395 | 0.200 |
Why?
| | Iliac Artery | 2 | 2020 | 43 | 0.190 |
Why?
| | Paclitaxel | 1 | 2022 | 190 | 0.190 |
Why?
| | Patient Readmission | 5 | 2019 | 610 | 0.190 |
Why?
| | Punctures | 2 | 2018 | 36 | 0.180 |
Why?
| | Heart Failure, Systolic | 1 | 2021 | 20 | 0.180 |
Why?
| | Troponin | 1 | 2021 | 44 | 0.180 |
Why?
| | Hospitals, Community | 1 | 2020 | 45 | 0.170 |
Why?
| | Multivariate Analysis | 4 | 2017 | 1430 | 0.170 |
Why?
| | Lithotripsy | 1 | 2020 | 40 | 0.170 |
Why?
| | Assisted Circulation | 1 | 2019 | 25 | 0.170 |
Why?
| | Chi-Square Distribution | 2 | 2017 | 493 | 0.170 |
Why?
| | Hemostatic Techniques | 1 | 2020 | 40 | 0.170 |
Why?
| | Elective Surgical Procedures | 1 | 2020 | 151 | 0.160 |
Why?
| | Postoperative Hemorrhage | 1 | 2020 | 74 | 0.160 |
Why?
| | Access to Information | 1 | 2019 | 47 | 0.160 |
Why?
| | Chronic Disease | 2 | 2023 | 1578 | 0.160 |
Why?
| | Thrombosis | 1 | 2022 | 298 | 0.160 |
Why?
| | Electrocardiography, Ambulatory | 1 | 2019 | 54 | 0.160 |
Why?
| | Intra-Aortic Balloon Pumping | 1 | 2019 | 16 | 0.160 |
Why?
| | Endocrinologists | 1 | 2018 | 12 | 0.160 |
Why?
| | Quality Improvement | 2 | 2019 | 950 | 0.160 |
Why?
| | Cross-Sectional Studies | 2 | 2019 | 4410 | 0.160 |
Why?
| | Atrioventricular Block | 1 | 2019 | 37 | 0.160 |
Why?
| | Laser Therapy | 1 | 2019 | 100 | 0.150 |
Why?
| | Cardiac Surgical Procedures | 1 | 2022 | 414 | 0.150 |
Why?
| | Stroke Volume | 1 | 2021 | 504 | 0.150 |
Why?
| | Office Visits | 1 | 2018 | 79 | 0.150 |
Why?
| | Delivery of Health Care, Integrated | 2 | 2018 | 228 | 0.150 |
Why?
| | Ambulatory Surgical Procedures | 1 | 2018 | 48 | 0.150 |
Why?
| | Heart Block | 1 | 2018 | 38 | 0.150 |
Why?
| | Ventricular Function, Left | 1 | 2021 | 467 | 0.150 |
Why?
| | Thromboembolism | 1 | 2018 | 92 | 0.140 |
Why?
| | Carotid Artery, Internal | 1 | 2017 | 36 | 0.140 |
Why?
| | Hospitalization | 4 | 2021 | 1752 | 0.140 |
Why?
| | Clinical Decision-Making | 2 | 2018 | 268 | 0.140 |
Why?
| | Echocardiography, Doppler, Color | 1 | 2017 | 39 | 0.140 |
Why?
| | American Heart Association | 1 | 2018 | 264 | 0.140 |
Why?
| | Cardiology | 1 | 2019 | 259 | 0.140 |
Why?
| | Mitral Valve Insufficiency | 1 | 2017 | 63 | 0.140 |
Why?
| | Decision Making | 2 | 2021 | 782 | 0.140 |
Why?
| | Patient Admission | 1 | 2018 | 176 | 0.140 |
Why?
| | Echocardiography, Transesophageal | 1 | 2017 | 89 | 0.140 |
Why?
| | Heart Valve Prosthesis | 1 | 2018 | 121 | 0.130 |
Why?
| | Angiography | 1 | 2017 | 174 | 0.130 |
Why?
| | Antihypertensive Agents | 1 | 2019 | 429 | 0.130 |
Why?
| | Patient Care Planning | 1 | 2016 | 139 | 0.130 |
Why?
| | Angina, Unstable | 1 | 2016 | 72 | 0.130 |
Why?
| | Electronic Health Records | 2 | 2019 | 800 | 0.130 |
Why?
| | Outpatients | 1 | 2018 | 326 | 0.120 |
Why?
| | Prospective Studies | 4 | 2020 | 6220 | 0.120 |
Why?
| | Proportional Hazards Models | 2 | 2016 | 1075 | 0.120 |
Why?
| | Cause of Death | 2 | 2019 | 361 | 0.120 |
Why?
| | Body Weight | 1 | 2019 | 869 | 0.120 |
Why?
| | Clinical Trials as Topic | 1 | 2019 | 932 | 0.120 |
Why?
| | Acute Disease | 1 | 2017 | 911 | 0.110 |
Why?
| | Cardiopulmonary Resuscitation | 1 | 2016 | 223 | 0.110 |
Why?
| | Echocardiography | 1 | 2016 | 553 | 0.110 |
Why?
| | Recovery of Function | 1 | 2017 | 574 | 0.110 |
Why?
| | Blood Pressure | 1 | 2019 | 1538 | 0.110 |
Why?
| | Pacemaker, Artificial | 2 | 2018 | 106 | 0.110 |
Why?
| | Severity of Illness Index | 4 | 2022 | 2540 | 0.110 |
Why?
| | Hospitals | 2 | 2019 | 581 | 0.100 |
Why?
| | Attitude of Health Personnel | 1 | 2019 | 975 | 0.100 |
Why?
| | Overweight | 1 | 2016 | 472 | 0.100 |
Why?
| | Longitudinal Studies | 1 | 2018 | 2387 | 0.100 |
Why?
| | Michigan | 3 | 2022 | 96 | 0.100 |
Why?
| | Hypertension | 1 | 2019 | 1056 | 0.100 |
Why?
| | Tunica Intima | 1 | 2010 | 78 | 0.090 |
Why?
| | Carotid Arteries | 1 | 2010 | 180 | 0.080 |
Why?
| | Constriction, Pathologic | 2 | 2020 | 208 | 0.080 |
Why?
| | Body Mass Index | 1 | 2016 | 1959 | 0.080 |
Why?
| | Prosthesis-Related Infections | 1 | 2009 | 70 | 0.080 |
Why?
| | Databases, Factual | 3 | 2019 | 1125 | 0.080 |
Why?
| | Mortality | 2 | 2020 | 287 | 0.080 |
Why?
| | Emergency Service, Hospital | 1 | 2018 | 1820 | 0.070 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2020 | 2096 | 0.070 |
Why?
| | Arrhythmias, Cardiac | 1 | 2009 | 279 | 0.070 |
Why?
| | Defibrillators, Implantable | 1 | 2009 | 286 | 0.060 |
Why?
| | Program Evaluation | 2 | 2017 | 822 | 0.050 |
Why?
| | Prevalence | 2 | 2019 | 2251 | 0.050 |
Why?
| | Kaplan-Meier Estimate | 2 | 2017 | 811 | 0.050 |
Why?
| | Angina Pectoris | 1 | 2020 | 63 | 0.040 |
Why?
| | Glucagon-Like Peptide-1 Receptor | 1 | 2020 | 72 | 0.040 |
Why?
| | Colorado | 2 | 2019 | 4100 | 0.040 |
Why?
| | Sodium | 1 | 2020 | 183 | 0.040 |
Why?
| | Health Facilities | 1 | 2019 | 72 | 0.040 |
Why?
| | Heart | 1 | 2022 | 612 | 0.040 |
Why?
| | Intraoperative Period | 1 | 2019 | 51 | 0.040 |
Why?
| | Comparative Effectiveness Research | 1 | 2019 | 130 | 0.040 |
Why?
| | California | 1 | 2019 | 353 | 0.040 |
Why?
| | Echocardiography, Stress | 1 | 2017 | 20 | 0.040 |
Why?
| | Postoperative Period | 1 | 2018 | 289 | 0.040 |
Why?
| | Combined Modality Therapy | 1 | 2020 | 1121 | 0.040 |
Why?
| | Recurrence | 1 | 2019 | 935 | 0.030 |
Why?
| | Quality Indicators, Health Care | 1 | 2019 | 287 | 0.030 |
Why?
| | Health Services Needs and Demand | 1 | 2018 | 243 | 0.030 |
Why?
| | Consensus | 1 | 2018 | 537 | 0.030 |
Why?
| | Statistics as Topic | 1 | 2016 | 292 | 0.030 |
Why?
| | Vasodilator Agents | 1 | 2017 | 302 | 0.030 |
Why?
| | Glucose | 1 | 2020 | 897 | 0.030 |
Why?
| | Treatment Failure | 1 | 2016 | 331 | 0.030 |
Why?
| | Patient Selection | 1 | 2018 | 641 | 0.030 |
Why?
| | Critical Illness | 1 | 2019 | 646 | 0.030 |
Why?
| | Pandemics | 1 | 2022 | 1320 | 0.030 |
Why?
| | Coronary Disease | 1 | 2016 | 348 | 0.030 |
Why?
| | Hypoglycemic Agents | 1 | 2020 | 1013 | 0.030 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2016 | 358 | 0.030 |
Why?
| | Guideline Adherence | 1 | 2016 | 490 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2019 | 2765 | 0.020 |
Why?
| | Morbidity | 1 | 2009 | 280 | 0.020 |
Why?
| | Ultrasonography | 1 | 2010 | 634 | 0.020 |
Why?
| | Pulmonary Embolism | 1 | 2009 | 181 | 0.020 |
Why?
| | Academic Medical Centers | 1 | 2009 | 411 | 0.020 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2010 | 1214 | 0.020 |
Why?
| | Young Adult | 1 | 2018 | 10471 | 0.010 |
Why?
| | Adult | 2 | 2018 | 30553 | 0.010 |
Why?
| | Adolescent | 1 | 2018 | 17853 | 0.010 |
Why?
|
|
Valle's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|